VERZENIO: payments to doctors
Payments that named VERZENIO as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $8.7M
- Providers
- 12,053
- Transactions
- 68,133
- Average per transaction
- $128
The per-transaction average — $128 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12,053 providers the average total is $726, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Lilly USA, LLC | $8,427,498 | 96.4% |
| Eli Lilly | $185,006 | 2.1% |
| Eli Lilly Export S.A. Puerto Rico Branch | $133,262 | 1.5% |